Detalles de la búsqueda
1.
Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein-Barr virus DNA level.
BMC Cancer
; 20(1): 89, 2020 Feb 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32013967
2.
Symptomatic venous thromboembolism associated with peripherally inserted central catheters predicts a worse survival in nasopharyngeal carcinoma: results of a large cohort, propensity score-matched analysis.
BMC Cancer
; 18(1): 1297, 2018 Dec 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-30594171
3.
Prognostic Value of Serum Epstein-Barr Virus Antibodies and Their Correlation with TNM Classification in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma.
Cancer Res Treat
; 53(4): 991-1003, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33494127
4.
The Characteristics and Survival Outcomes in Patients Aged 70 Years and Older with Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era.
Cancer Res Treat
; 51(1): 34-42, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29409313
5.
Combining pretreatment plasma Epstein-Barr virus DNA level and cervical node necrosis improves prognostic stratification in patients with nasopharyngeal carcinoma: A cohort study.
Cancer Med
; 8(16): 6841-6852, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31513364
6.
Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on induction chemotherapy response.
Radiother Oncol
; 137: 83-94, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31078941
Resultados
1 -
6
de 6
1
Próxima >
>>